DONDI, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 3869
NA - Nord America 1897
AS - Asia 998
SA - Sud America 45
OC - Oceania 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6822
Nazione #
GB - Regno Unito 1917
US - Stati Uniti d'America 1848
DE - Germania 718
CN - Cina 530
SE - Svezia 359
IT - Italia 317
TR - Turchia 196
UA - Ucraina 158
KR - Corea 156
RU - Federazione Russa 111
EU - Europa 102
NL - Olanda 88
FI - Finlandia 85
CA - Canada 44
IN - India 38
CO - Colombia 35
PH - Filippine 31
GR - Grecia 28
FR - Francia 23
VN - Vietnam 21
RO - Romania 12
DK - Danimarca 11
PL - Polonia 8
ES - Italia 7
BR - Brasile 6
JP - Giappone 6
AU - Australia 5
BE - Belgio 5
CH - Svizzera 5
HK - Hong Kong 4
TW - Taiwan 4
CL - Cile 3
HU - Ungheria 3
MX - Messico 3
NO - Norvegia 3
PT - Portogallo 3
AT - Austria 2
ET - Etiopia 2
IE - Irlanda 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
CU - Cuba 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PE - Perù 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 6922
Città #
Southend 1847
Hanover 379
Seattle 269
Princeton 171
Milan 141
Wilmington 141
Redmond 126
Jacksonville 116
Beijing 115
Ann Arbor 110
Woodbridge 97
Fairfield 92
Nanjing 78
Sakarya 78
Mountain View 67
Des Moines 62
Dearborn 55
Chandler 51
Houston 48
Munich 48
Somerville 42
Shenyang 41
Andover 40
Toronto 39
Cambridge 37
Ashburn 36
Bogotá 35
Jinan 31
Athens 29
Grafing 26
Norwalk 26
Redwood City 24
Nanchang 23
Serra 23
Zhengzhou 23
Changsha 22
Bitonto 21
Medford 20
Lanzhou 17
San Diego 17
Guangzhou 16
Tianjin 16
Berlin 15
Hangzhou 15
Kiez 15
Ningbo 15
Hebei 14
Jiaxing 14
Roxbury 12
Shanghai 12
Haikou 11
Sunnyvale 10
Taizhou 10
Auburn Hills 9
Phoenix 8
London 7
Nürnberg 7
Warsaw 7
Fuzhou 6
Istanbul 6
Falls Church 5
Brussels 4
Dong Ket 4
Hamburg 4
Hefei 4
Helsinki 4
Kunming 4
Los Angeles 4
Taiyuan 4
Tokyo 4
Turin 4
Verona 4
Chengdu 3
Detroit 3
Erlangen 3
Kwai Chung 3
New Delhi 3
Oslo 3
Prato 3
Amsterdam 2
Bari 2
Budapest 2
Costa Mesa 2
Frankfurt Am Main 2
Geneva 2
Harbin 2
Ivanov 2
Lakewood 2
Madrid 2
Manila 2
Mumbai 2
New York 2
Rome 2
Seoul 2
Silver Spring 2
São Paulo 2
Taipei 2
Tampa 2
Tennyson 2
Vancouver 2
Totale 5000
Nome #
The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway 340
Antiproliferative effect of mifepristone ({RU}486) on human neuroblastoma cells ({SK}-N-{SH}): in vitro and in vivo studies 186
Expression and differential effects of the activation of glucocorticoid receptors in mouse gonadotropin-releasing hormone neurons 179
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion 165
Biologia Cellulare 160
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol 154
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells 149
Role of glucocorticoids in the migration of immature LHRH neurons 117
Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study 116
Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism 114
Effect of oestrus cyclicity on the number of brain opioid mu receptors in the rat 112
Dexamethasone modulates differentiation and motility of SK-N-SH human neuroblastoma cells 109
Aging and the hypothalamo-pituitary-testicular axis in the rat 108
Hypothalamic ß-endorphin and brain mu opiate receptor concentrations in male rat after restraint stress 101
Estrogen receptor beta and the progression of prostate cancer - role of 5alpha-androstane-3beta,17beta-diol (3beta-Adiol) 100
Regolazione del sistema attivatore del plasminogeno da parte degli ormoni glucocorticoidi nella progressione metastatica del cancro prostatico 100
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop 100
In vivo growth properties and molecular marker expression of DU145 human prostate tumor cells expressing recombinant androgen receptor 97
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 96
Effects of aging on pituitary and testicular luteinizing hormone-releasing hormone receptors in the rat 95
Role of estrogen receptor β in the pathogenesis and progression of prostate cancer 94
Endocrinology of aging 92
Antiproliferative action of melatonin on human prostate cancer LNCaP cells 91
Role of Estrogen Receptor beta on prostate cancer cell migration 90
Endocrine responses to naloxone in young and old male rats. 90
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP 89
Involvment of the glucocorticoid receptor in the migration of GN11 LHRH neurons 88
Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148 88
Gonadal steroid modulation of brain opioid systems 88
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH 88
The EGF/TGFalpha system as an autocrine growth stimulatory loop in LNCaP cells 87
Morphine stimulates prolactin release in normal but not in castrated male rats 84
Modulation by sex steroids of brain opioid receptors: implications for the control of gonadotropins and prolactin secretion 84
Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth 84
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system 83
Involvment of Glucocorticoid receptors in the migratore activity of immortalized GnRH secreting neurons 83
Characterization of a soluble LHRH-degrading activity in the rat ventral prostate 83
Sex steroids and brain opioid receptors 83
Distribution of kappa opioid receptors in the brain of young and old male rats 82
Expression and role of glucocorticoid receptors in mouse neurons secretine gonadotropin releasing hormons 81
Antiproliferative action of RU486 on human neuroblastoma cells (SK-N-SH) 81
Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors 81
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 81
Effect of glucocorticoids on the plasminogen activator system in the metastatic progression of prostate cancer 80
Effect of LHRH analogs on the Urokinase Receptor in the metastatic progression of prostate cancer 80
Peptide-steroid interactions in the modulation of the hypothalamic-pituitary axis 80
LRHR as a growth-inhibitory factor in prostatic tumor cells: possible mechanism of action 80
Testosterone and postnatal ontogenesis of hypothalamic mu ([3H]dihydromorphine) opioid receptors in the rat 80
Dexamethasone blocks the migration of the human neuroblastoma cell line SK-N-SH 78
Role of estrogen receptor beta in the progression of prostate cancer 78
Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat 78
Growth factors in steroid-responsive prostatic tumor cells 78
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines 77
Effect of aging on opioid and LHRH receptors in the brain, pituitary, and testis of the male rat 77
Meccanismo d'azione degli ormoni 76
La progressione metastatica del cancro prostatico umano: effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno 76
Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice 76
Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145 75
The metastatic progression of prostate cancer effect of LHRH analogs on plasminogen activator system 75
Further evidence that gonadal steroids do not modulate brain opiate receptors in male rats 74
Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat 74
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145 73
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion 72
The metastatic progression of prostate cancer : effect of LHRH analogs on plasminogen activator system 71
Soluble urokinase-type plasminogen activation receptor inhibits prostate cancer cell growth and invasion 71
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor 71
Binding characteristics of delta opioid receptors in different regions of the brain of young and old male rats as studied with the highly selective ligand [D-Pen2-D-Pen5] enkephalin 69
Effetto degli analoghi dell’LHRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano” 68
Effetto degli analoghi del GnRH sul sistema attivatore del plasminogeno nella progressione metastatica del cancro prostatico umano 68
Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat 68
Role of GnRH analogs in the control of the plasminogen activator system in human prostate cancer cell lines 67
Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP 66
Effect of ovarian steroids on the concentration of mu opiate receptors in different regions of the brain of the female rat 64
Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion 64
GnRH analogues inhibit the plasminogen activator system and the metastatic progression of prostate cancer 63
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors 57
Epigenetic control of pi3k/akt activity in prostate cancer during hormone manipulation 57
Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids 54
Mechanism of action of interleukin-1 in modulating gonadotropin secretion. In vivo and in vitro studies 52
Effects of steroids on the brain opioid system 52
Effects of ovarian hormones on brain opioid binding sites in castrated female rats 50
Dosimetric analysis of phenolic solid state pellets exposed to radio-therapeutic photon and electron beams through electron spin resonance technique=Analisi dosimetrica di composti fenolici irradiati con fasci clinici di fotoni ed elettroni tramite spettroscopia di risonanza di spin elettronico 38
Biology of hypothalamic neurons producing gonadotropin-releasing hormone (GnRH): new information on the use of immortalized cells secreting GnRH 33
Totale 7413
Categoria #
all - tutte 8737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018747 09964162 9136 5635 55318515
2018/20191059 254846865 6159 9829 982511360
2019/20201004 136215555 43107 13864 1941343918
2020/20211192 136111743 16197 4741 1378828998
2021/20221276 771912160 10467 7388 214112140201
2022/2023193 1385500 00 00 0000
Totale 7413